Literature DB >> 33379260

Air Pollution-An Overlooked Risk Factor for Idiopathic Pulmonary Fibrosis.

Sebastian Majewski1, Wojciech J Piotrowski1.   

Abstract

Air pollution is a major environmental risk to health and a global public health concern. In 2016, according to the World Health Organization (WHO), ambient air pollution in cities and rural areas was estimated to cause 4.2 million premature deaths. It is estimated that around 91% of the world's population lives in places where air pollution exceeds the limits recommended by the WHO. Sources of air pollution are multiple and context-specific. Air pollution exposures are established risk factors for development and adverse health outcomes in many respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), or lung cancer. However, possible associations between air pollution and idiopathic pulmonary fibrosis (IPF) have not been adequately studied and air pollution seems to be an underrecognized risk factor for IPF. This narrative review describes potential mechanisms triggered by ambient air pollution and their possible roles in the initiation of the pathogenic process and adverse health effects in IPF. Additionally, we summarize the most current research evidence from the clinical studies supporting links between air pollution and IPF.

Entities:  

Keywords:  IPF; air pollution; health outcomes; idiopathic pulmonary fibrosis; risk factors

Year:  2020        PMID: 33379260     DOI: 10.3390/jcm10010077

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  8 in total

Review 1.  Dysfunction of epithelial permeability barrier induced by HMGB1 in 2.5D cultures of human epithelial cells.

Authors:  Takashi Kojima; Yuma Shindo; Takumi Konno; Yuki Kodera; Wataru Arai; Maki Miyakawa; Kizuku Ohwada; Hiroki Tanaka; Mitsuhiro Tsujiwaki; Yuji Sakuma; Shin Kikuchi; Tsuyoshi Ohkuni; Kenichi Takano; Atsushi Watanabe; Takayuki Kohno
Journal:  Tissue Barriers       Date:  2021-09-18

2.  p300/Sp1-Mediated High Expression of p16 Promotes Endothelial Progenitor Cell Senescence Leading to the Occurrence of Chronic Obstructive Pulmonary Disease.

Authors:  Zhihui He; Huaihuai Peng; Min Gao; Guibin Liang; Menghao Zeng; Xuefeng Zhang
Journal:  Mediators Inflamm       Date:  2021-08-19       Impact factor: 4.711

3.  Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis.

Authors:  Sebastian Majewski; Karolina Szewczyk; Hanna Jerczyńska; Joanna Miłkowska-Dymanowska; Adam J Białas; Łukasz Gwadera; Wojciech J Piotrowski
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

4.  Air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Beijing: a time-series study.

Authors:  Lirong Liang; Yutong Cai; Baolei Lyu; Di Zhang; Shuilian Chu; Hang Jing; Kazem Rahimi; Zhaohui Tong
Journal:  Respir Res       Date:  2022-04-05

Review 5.  Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside.

Authors:  Teng Huang; Jia Gao; Long Cai; Hao Xie; Yuhan Wang; Yi Wang; Qing Zhou
Journal:  Pharmaceutics       Date:  2022-04-07       Impact factor: 6.525

6.  Double Lung Transplantation for Idiopathic Pulmonary Fibrosis in a Patient with a History of Liver Transplantation and Prolonged Journey for Disease-Specific Antifibrotic Therapy.

Authors:  Sebastian Majewski; Maria Królikowska; Ulrich Costabel; Wojciech J Piotrowski; Marek Ochman
Journal:  Case Rep Pulmonol       Date:  2022-08-13

7.  PM2.5 Exposure Induces Lung Injury and Fibrosis by Regulating Ferroptosis via TGF-β Signaling.

Authors:  Li Guo; Shuping Bai; Shaohua Ding; Ling Zhao; Shanqi Xu; Xiaohong Wang
Journal:  Dis Markers       Date:  2022-09-27       Impact factor: 3.464

8.  Clinical characteristics and histopathology of COVID-19 related deaths in South African adults.

Authors:  Marta C Nunes; Martin J Hale; Sana Mahtab; Fikile C Mabena; Noluthando Dludlu; Vicky L Baillie; Bukiwe N Thwala; Toyah Els; Jeanine du Plessis; Marius Laubscher; Shakeel Mckenzie; Sihle Mtshali; Colin Menezes; Natali Serafin; Sarah van Blydenstein; Merika Tsitsi; Brian Dulisse; Shabir A Madhi
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.